Monitor the appointment of the next Medical Essentials president for any strategic shifts. The direct reporting of BioPharma Systems to the CEO signals its importance as a growth driver, but no immediate trading catalyst is present.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 22 $153.16entry
- T+1 · 4mo ago −0.12%α +1.11% · $152.97
- T+5 · 4mo ago +9.95%α +12.35% · $168.40
- T+20 · 3mo ago +22.49%α +19.59% · $187.60
- T+60 · 5w ago +26.51%α +23.25% · $193.76
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BDX announced the retirement of EVP and segment President Mike Garrison, effective Oct. 2, 2026, after 20+ years. The BioPharma Systems segment will report directly to CEO Tom Polen, streamlining the operating model. This is a routine executive transition with no financial impact; a search for the next Medical Essentials president is underway.
Key Facts
- EVP Michael D. Garrison retiring after 20+ years, effective Oct. 2, 2026
- BioPharma Systems segment will report directly to CEO Tom Polen going forward
- Comprehensive search underway for next President of Medical Essentials segment
- Garrison remains in role through end of fiscal year to support transition
Financial Impact
No financial figures disclosed; routine executive retirement with no material financial impact.
Risk Factors
- Potential leadership vacuum if successor search is prolonged
- Uncertainty around strategic direction of Medical Essentials segment under new leadership
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001628280-26-049103 |
| Document: bdnews_medessentialsbpsxpr.htm | 0001628280-26-049103 |
| Document: 0001628280-26-049103-index-headers.html | 0001628280-26-049103 |
| Document: 0001628280-26-049103-index.html | 0001628280-26-049103 |
| Document: 0001628280-26-049103.txt | 0001628280-26-049103 |
Track record
17 reports on BDX
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 10, 20265d ago 144 Neutral 2/10 Entry $214.52 Now $216.47 +0.91% settles Nov 18
- Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $211.88 to $218.03 Now $216.47 +2.17% ▲ +2.90% +0.31% vs SPY
- Nov 5, 202611d ago 8-K Bullish 6/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
- Nov 5, 202611d ago Press Release Neutral 3/10 Entry $213.55 to $215.71 Now $216.47 +1.37% ▲ +1.01% −2.28% vs SPY
- Nov 4, 202612d ago Press Release Neutral 2/10 Entry $209.19 to $214.52 Now $216.47 +3.48% ▲ +2.55% +3.46% vs SPY
- Oct 26, 202621d ago 144 Neutral 2/10 Entry $195.03 to $198.17 Now $216.47 +10.99% ▲ +1.61% +3.60% vs SPY
- Oct 6, 20265w ago Press Release Neutral 2/10 Entry $180.30 to $187.37 Now $216.47 +20.06% ▲ +3.92% +4.06% vs SPY
- Aug 14, 202613w ago Insider Cluster Neutral 2/10 Entry $182.09 to $190.74 Now $216.47 +18.88% ▲ +4.75% +5.94% vs SPY
- Jul 22, 202616w ago 8-K Neutral 2/10 Viewing Entry $153.16 to $168.40 Now $216.47 +41.34% ▲ +9.95% +12.35% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers